Kazakhstan discloses volume of doses to be produced by COVID-19 vaccine plant

Business Materials 2 December 2020 15:07 (UTC +04:00)
Kazakhstan discloses volume of doses to be produced by COVID-19 vaccine plant

BAKU, Azerbaijan, Dec. 2


A plant for the production of a vaccine against coronavirus is being built in Kazakhstan’s Zhambyl region upon the president’s order, Governor of the region Berdibek Saparbayev said at a briefing at the Central Communications Service, Trend reports.

“Its approximate cost is almost seven billion tenge,” the governor said. “The production capacity is 30-60 million doses per year.”

“Presently, this plant produces vaccines against brucellosis, dermatitis, and bird flu,” Saparbayev said. “These are the medicines that are associated with increasing the immunity of both animals and humans.”

“All construction work at the plant will be completed till the end of the year,” the governor said. “The installation of the necessary equipment, fixtures, lines, and so on will begin from January-February 2021.”

“In accordance with the plan, the vaccine will be prepared in March, when the third phase of clinical tests is over,” Saparbayev said. “The capacity is from 30 million to 60 million doses per year.”

“As for ensuring biological safety, the research institute, taking into account the international requirements, created all the necessary conditions,” the governor said.

“All these conditions have been taken into account,” Saparbayev said. “The most important thing is storage, the second is a transportation and the safety of the institute employees during the production and preparation of vaccines.”

The rapid coronavirus tests and disposable syringes are planned to be produced in the region. More than two billion tenge is envisaged for the construction of the plant.

The plant will be commissioned during December. Thus, scientists of the Zhambyl region intend to make a breakthrough in the production of medicines and medical devices.